Dr. Christina Parks, Ph.D. ( COVID-19: A Second Opinion Roundtable)

Christina Parks is a Ph.D. holder in cellular and molecular biology.
COVID-19: A Second Opinion roundtable
https://rumble.com/vt62y6-covid-19-a-second-opinion.html
Parks received her PhD in Cellular and Molecular Biology from the University of Michigan. She is an expert on knowing which vaccines may cause injury to vulnerable immune systems. She is also an outspoken critic of the misinformation campaign against hydroxychloroquine.
In the early months of the spread of the virus, hydroxychloroquine was immediately shut down as a cure by the media, Big Tech, government agencies, and the medical establishment, which mostly cited studies which linked high death rates to the drug.
Parks explained that these studies took data from patients who were given too many doses. She says that “any reasonable doctor would know that this was basically trying to kill these patients.”
Dr. Parks noted how several years ago, hydroxychloroquine was discovered in research and tests to be a drug which contains “strong antiviral activity.” Hydroxychloroquine’s level of effectiveness in combating malaria made it a wonder drug, she added.
“What is going on [in the banning of hydroxychloroquine] is the equivalent of denying everyone in America antibiotics,” Dr. Parks said.
Hydroxychloroquine functions together with Zinc, she explained, to enter “into the cells and stop the virus from replicating.” She also pointed to other products such as green tea, quercetin, or quinine in tonic water, which can have effects similar to hydroxychloroquine. If used at extremely low doses, HCQ may “help prevent transmission and infection,” and it will “stay in the body [for] fifty days.”
With all this scientific research out there, Parks asked, “Why hasn’t this information been disseminated?” She said “it was shut down for what I can only say is purely political reasons.”
Parks mentioned several studies, including one from the Henry Ford Medical System in Michigan, which have found the mortality rate of patients who have taken HCQ reduced by 50 percent or more.
https://www.lifesitenews.com/.../the-anti.../